AJANTA PHARMA Announces Quarterly Results (2QFY19); Net Profit Down 4.9%

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AJANTA PHARMA Announces Quarterly Results (2QFY19); Net Profit Down 4.9%
Tue, 6 Nov

AJANTA PHARMA has announced its results for the quarter ended September 2018. Here is a detailed performance review of the same:

AJANTA PHARMA Quarterly Financials

No. of Mths
Qtr. Ending
3
Sep-17*
3
Jun-18*
3
Sep-18*
QoQ ChangeYoY Change
Net SalesRs m5,4045,1105,4416.5%0.7%
Other incomeRs m928115287.5%66.0%
TurnoverRs m5,4965,1915,5947.7%1.8%
ExpensesRs m3,5673,5353,7796.9%6.0%
Gross profitRs m1,8371,5751,6625.5%-9.5%
DepreciationRs m1461721751.9%20.2%
InterestRs m121-23.5%44.4%
Profit before taxRs m1,7831,4831,63810.5%-8.1%
TaxRs m464425385-9.5%-17.1%
Profit after taxRs m1,3191,0581,25418.5%-4.9%
Gross profit margin%34.030.830.5
Effective tax rate%26.028.723.5
Net profit margin%24.020.422.4
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Reports, Regulatory Filings, Equitymaster


Year-on-Year Performance:
  • The company's operating income during the quarter grew 0.7% on a year-on-year (YoY) basis. The expenses were up by 6.0% YoY during the same period.
  • The company's operating profit declined by 9.5% YoY during the quarter. Consequently, operating profit margins witnessed a decline and stood at 30.5% in 2QFY19 as against 34.0% in 2QFY18.
  • Depreciation charges increased by 20.2% and finance costs increased by 44.4% YoY, respectively.
  • Other income increased by 66.0% YoY during the quarter.
  • Net profit for the quarter declined by 4.9% YoY. Net profit margins during the quarter declined from 24.0% in 2QFY18 to 22.4% in 2QFY19.
Quarter-on-Quarter Performance:
  • The company's operating income during the quarter grew 6.5% on a quarter-on-quarter (QoQ) basis. The expenses were up by 6.9% QoQ during the same period.
  • The company's operating profit declined by 5.5% QoQ during the quarter. Consequently, operating profit margins witnessed a decline and stood at 30.5% in 2QFY19 as against 30.8% in 1QFY18.
  • Net profit for the quarter increased by 18.5% QoQ, while net profit margins increased from 20.4% in 1QFY18 to 22.4% in 2QFY19.

To see how AJANTA PHARMA has performed over the last eight quarters, please visit here.

AJANTA PHARMA Share Price Performance

Over the last one year, AJANTA PHARMA share price has moved up from Rs 1,232.2 to Rs 1,064.4, registering a Loss of Rs 167.8 or around 13.6%.

Meanwhile, the S&P BSE HEALTHCARE Index is trading at Rs 14,467.5 (down 0.0%). Over the last one year it has moved down from 14,548.5 to 14,467.5, a gain of 81 points (down 0.6%).

Overall, the S&P BSE SENSEX is up 4.0% over the year.

Current Valuations

At the current price of Rs 1,064.4, the price to earnings (P/E) ratio of AJANTA PHARMA stands at 19.8 times its trailing twelve months earnings, while its price to book value (P/BV) ratio stands at 4.6 times.

Equitymaster requests your view! Post a comment on "AJANTA PHARMA Announces Quarterly Results (2QFY19); Net Profit Down 4.9%". Click here!

  

Related Views on News

AJANTA PHARMA Announces Quarterly Results (4QFY20); Net Profit Up 45.3% (Quarterly Result Update)

May 21, 2020 | Updated on May 21, 2020

For the quarter ended March 2020, AJANTA PHARMA has posted a net profit of Rs 1 bn (up 45.3% YoY). Sales on the other hand came in at Rs 7 bn (up 32.4% YoY). Read on for a complete analysis of AJANTA PHARMA's quarterly results.

AJANTA PHARMA Announces Quarterly Results (3QFY20); Net Profit Up 60.8% (Quarterly Result Update)

Feb 6, 2020 | Updated on Feb 6, 2020

For the quarter ended December 2019, AJANTA PHARMA has posted a net profit of Rs 1 bn (up 60.8% YoY). Sales on the other hand came in at Rs 7 bn (up 34.2% YoY). Read on for a complete analysis of AJANTA PHARMA's quarterly results.

AJANTA PHARMA 2018-19 Annual Report Analysis (Annual Result Update)

Jun 24, 2019 | Updated on Jun 24, 2019

Here's an analysis of the annual report of AJANTA PHARMA for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of AJANTA PHARMA. Also includes updates on the valuation of AJANTA PHARMA.

More Views on News

Most Popular

6 Charts Showing the State of Indian Financial Markets in 2020(Sector Info)

May 26, 2020

Six charts showing how Indian financial markets have performed in 2020 so far...

Why We Picked This Smallcap Stock for a Post Coronavirus World(Profit Hunter)

May 28, 2020

Covid-19 has made it a survival of the fittest race for many companies. The ones that can adapt will thrive in a post crisis world.

What the RBI's Rate Cut Means for Options Traders(Fast Profits Daily)

May 25, 2020

The RBI governor has cut the repo rate to 4%. What does this mean for options traders? Find out in this video.

Who Will Be Crowned the 'Multibagger Blue Chip' of the Decade?(Profit Hunter)

May 25, 2020

Will the mutlibagger blue chips of the past decade continue to rule the bourses?

More

India's #1 Trader
Reveals His Secrets

The Secret to Increasing Your Trading Profits Today
Get this Special Report, The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

AJANTA PHARMA SHARE PRICE


Jun 5, 2020 01:59 PM

TRACK AJANTA PHARMA

  • Track your investment in AJANTA PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

AJANTA PHARMA 5-YR ANALYSIS

COMPARE AJANTA PHARMA WITH

MARKET STATS